Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.35
+0.13 (2.09%)
Mar 11, 2026, 1:05 PM EDT - Market open

Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories.

It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Inogen, Inc.
Inogen logo
CountryUnited States
Founded2001
IPO DateFeb 14, 2014
IndustryMedical Devices
SectorHealthcare
Employees753
CEOKevin R. Smith

Contact Details

Address:
500 Cummings Center, Suite 2800
Beverly, Massachusetts 01915
United States
Phone805 562 0500
Websiteprovider.inogen.com

Stock Details

Ticker SymbolINGN
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001294133
CUSIP Number45780L104
ISIN NumberUS45780L1044
SIC Code3842

Key Executives

NamePosition
Kevin R. M. SmithPresident, Chief Executive Officer and Director
Michael J. Bourque C.P.A.Executive Vice President, Chief Financial Officer and Corporate Treasurer
Kevin P. SmithGeneral Counsel, Secretary and Executive Vice President of Business Development
Grgoire RamadeExecutive Vice President and Chief Commercial Officer
Philip CorrinSenior Vice President of Operations and Supply Chain
Mary WrightVice President and Chief Accounting Officer
Naga RameswamyChief Technology Officer
Lorna WilliamsSenior Vice President of Investor Relations
Jennifer Yi BoyerExecutive Vice President of Enterprise Enablement and Chief Human Resources Officer
Dr. Krishna JhaveriChief Medical Officer

Latest SEC Filings

DateTypeTitle
Feb 27, 2026S-8Securities to be offered to employees in employee benefit plans
Feb 27, 202610-KAnnual Report
Feb 24, 20268-KCurrent Report
Jan 12, 20268-KCurrent Report
Nov 6, 202510-QQuarterly Report
Nov 5, 20258-KCurrent Report
Aug 8, 202510-QQuarterly Report
Aug 7, 20258-KCurrent Report
Jul 29, 20258-KCurrent Report
Jul 17, 2025SCHEDULE 13G/AFiling